Parathyroid Hormone in the Treatment of Osteoporosis

被引：0
作者：
Takuo Fujita
机构：
[1] Katsuragi Hospital,
来源：
BioDrugs | 2001年 / 15卷
关键词：
Osteoporosis; Calcitonin; Raloxifene; Alendronic Acid; Lumbar Bone Mineral Density;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Parathyroid hormone (PTH), especially intact human PTH [hPTH(1–84)] and its various fragments [hPTH(1–31), (1–34), (1–36), (1–38) and their modifications], has been used for the treatment of osteoporosis over the last 10 years. Although chronic continuous excess of PTH markedly increases bone resorption, as seen in the typical example of primary hyperparathyroidism and osteitis fibrosa generalisata, intermittent PTH administration has been found to stimulate bone formation in animals, providing a basis for the use of PTH as a therapeutic agent for osteoporosis.
引用
收藏
页码：721 / 728
页数：7
相关论文
共 136 条
[31]  
Hesch R.D.(1999)Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone-(1–34): kinetics and biochemical responses in estrogenized osteoporotic patients J Bone Miner Res 14 S137-65
[32]  
Busch U.(2000)Parathyroid hormone 1–34 (PTH1–34) and estrogen produce dramatic bone density increases in postmenopausal osteoporosis J Bone Miner Res 15 S193-83
[33]  
Prokop M.(1999)PTH effects in the femur. Envelope-specific responses by 3DQCT in postmenopausal women J Bone Miner Res 14 675-5
[34]  
Hesch R.D.(1998)PTH-induced increases of bone density are preserved with estrogens: results from a follow-up year in postmenopausal osteoporosis Endocrinology 139 4642-48
[35]  
Heck J.(2001)The action of a raloxifene analog (LY117018) allows for reduced PTH (1–34) dosing during reversal of osteopenia in ovariectomized rats J Bone Miner Res 16 157-34
[36]  
Auf’mKolk B.(1991)LY 353381/HCl: an improved benzothiophene analog with bone efficacy complementary to parathyroid hormone-(1–34) Bone Miner 14 67-77
[37]  
Fraher L.J.(1998)Intermittently administered human parathyroid hormone (1–34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys J Bone Miner Res 13 1051-8S
[38]  
Avram R.(1993)Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1–38) and salmon calcitonin in osteoporotic patients J Clin Invest 91 1138-94
[39]  
Watson P.H.(2000)Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women J Clin Endocrinol 85 2129-8
[40]  
Mohan S.(1995)An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis J Bone Miner Res 10 S200-10
12345678910